Auxly Cannabis Group Inc. (XLY.TO)
CAD 0.08
(-6.25%)
CAD 0.08
(-6.25%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -44.51 Million CAD | 65.84% |
| 2022 | -130.29 Million CAD | -183.8% |
| 2021 | -45.91 Million CAD | 47.49% |
| 2020 | -87.43 Million CAD | 19.51% |
| 2019 | -108.61 Million CAD | -62.15% |
| 2018 | -66.98 Million CAD | -268.54% |
| 2017 | -18.17 Million CAD | -7817.51% |
| 2016 | -229.57 Thousand CAD | -805.37% |
| 2015 | 32.54 Thousand CAD | -12.78% |
| 2014 | 37.31 Thousand CAD | -40.1% |
| 2013 | 62.29 Thousand CAD | -40.79% |
| 2012 | 105.21 Thousand CAD | 24.86% |
| 2011 | 84.26 Thousand CAD | -0.11% |
| 2010 | 84.35 Thousand CAD | 98.74% |
| 2009 | 42.44 Thousand CAD | 298.39% |
| 2008 | -21.39 Thousand CAD | -40.84% |
| 2007 | -15.19 Thousand CAD | -100.17% |
| 2006 | 9.11 Million CAD | 249.62% |
| 2005 | -6.08 Million CAD | -28.21% |
| 2004 | -4.74 Million CAD | -170.85% |
| 2003 | -1.75 Million CAD | 74.9% |
| 2002 | -6.98 Million CAD | -283.49% |
| 2001 | 3.8 Million CAD | 153.17% |
| 2000 | -7.16 Million CAD | -1037.32% |
| 1999 | -629.72 Thousand CAD | -2092.56% |
| 1998 | -28.72 Thousand CAD | -84.63% |
| 1997 | -15.55 Thousand CAD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -26.01 Million CAD | 51.85% |
| 2024 Q2 | 2 Million CAD | 107.7% |
| 2023 Q3 | 32.62 Million CAD | 353.6% |
| 2023 FY | -44.51 Million CAD | 65.84% |
| 2023 Q4 | -54.02 Million CAD | -265.6% |
| 2023 Q1 | -16.05 Million CAD | -0.01% |
| 2023 Q2 | -12.86 Million CAD | 19.89% |
| 2022 FY | -130.29 Million CAD | -183.8% |
| 2022 Q4 | -16.05 Million CAD | 73.29% |
| 2022 Q3 | -60.1 Million CAD | -320.62% |
| 2022 Q1 | -39.84 Million CAD | -116.84% |
| 2022 Q2 | -14.28 Million CAD | 64.14% |
| 2021 Q3 | -13.52 Million CAD | -256.24% |
| 2021 Q1 | -10.49 Million CAD | 61.08% |
| 2021 Q4 | -18.37 Million CAD | -35.85% |
| 2021 FY | -45.91 Million CAD | 47.49% |
| 2021 Q2 | 8.65 Million CAD | 182.5% |
| 2020 Q1 | -12.74 Million CAD | 77.92% |
| 2020 FY | -87.43 Million CAD | 19.51% |
| 2020 Q2 | -27.91 Million CAD | -119.06% |
| 2020 Q4 | -26.96 Million CAD | -51.5% |
| 2020 Q3 | -17.79 Million CAD | 36.24% |
| 2019 Q1 | -13.61 Million CAD | 61.43% |
| 2019 FY | -108.61 Million CAD | -62.15% |
| 2019 Q2 | -13.98 Million CAD | -2.76% |
| 2019 Q3 | -17.25 Million CAD | -23.36% |
| 2019 Q4 | -57.72 Million CAD | -234.52% |
| 2018 Q1 | -10.52 Million CAD | -14.29% |
| 2018 Q4 | -35.29 Million CAD | -279.51% |
| 2018 FY | -66.98 Million CAD | -268.54% |
| 2018 Q2 | -11.88 Million CAD | -12.93% |
| 2018 Q3 | -9.29 Million CAD | 21.73% |
| 2017 FY | -18.17 Million CAD | -7817.51% |
| 2017 Q2 | -1.58 Million CAD | -6.62% |
| 2017 Q3 | -5.9 Million CAD | -272.81% |
| 2017 Q1 | -1.48 Million CAD | -344.06% |
| 2017 Q4 | -9.2 Million CAD | -55.93% |
| 2016 Q2 | 7238.00 CAD | -91.21% |
| 2016 Q4 | -334.44 Thousand CAD | -2284.92% |
| 2016 Q1 | 82.32 Thousand CAD | 3918.37% |
| 2016 FY | -229.57 Thousand CAD | -805.37% |
| 2016 Q3 | 15.3 Thousand CAD | 111.48% |
| 2015 Q3 | 10.56 Thousand CAD | -39.16% |
| 2015 FY | 32.54 Thousand CAD | -12.78% |
| 2015 Q1 | 6771.00 CAD | -65.91% |
| 2015 Q2 | 17.36 Thousand CAD | 156.48% |
| 2015 Q4 | -2156.00 CAD | -120.41% |
| 2014 Q4 | 19.86 Thousand CAD | 105.65% |
| 2014 FY | 37.31 Thousand CAD | -40.1% |
| 2014 Q2 | 5114.00 CAD | 90.75% |
| 2014 Q1 | 2681.00 CAD | -76.26% |
| 2014 Q3 | 9659.00 CAD | 88.87% |
| 2013 Q4 | 11.29 Thousand CAD | -28.23% |
| 2013 FY | 62.29 Thousand CAD | -40.79% |
| 2013 Q3 | 15.73 Thousand CAD | -20.51% |
| 2013 Q2 | 19.79 Thousand CAD | 27.84% |
| 2013 Q1 | 15.48 Thousand CAD | -53.61% |
| 2012 Q2 | 25.67 Thousand CAD | 10.9% |
| 2012 Q3 | 23.01 Thousand CAD | -10.36% |
| 2012 Q4 | 33.37 Thousand CAD | 45.03% |
| 2012 FY | 105.21 Thousand CAD | 24.86% |
| 2012 Q1 | 23.15 Thousand CAD | -36.57% |
| 2011 Q4 | 36.5 Thousand CAD | 128.91% |
| 2011 Q3 | 15.94 Thousand CAD | -5.45% |
| 2011 Q2 | 16.86 Thousand CAD | 12.76% |
| 2011 Q1 | 14.95 Thousand CAD | -50.48% |
| 2011 FY | 84.26 Thousand CAD | -0.11% |
| 2010 Q3 | 12.77 Thousand CAD | -54.57% |
| 2010 FY | 84.35 Thousand CAD | 98.74% |
| 2010 Q4 | 30.2 Thousand CAD | 136.49% |
| 2010 Q2 | 28.11 Thousand CAD | 111.83% |
| 2010 Q1 | 13.27 Thousand CAD | 1101.0% |
| 2009 Q2 | 11.67 Thousand CAD | 40.86% |
| 2009 Q4 | 1105.00 CAD | -94.83% |
| 2009 Q3 | 21.38 Thousand CAD | 83.17% |
| 2009 FY | 42.44 Thousand CAD | 298.39% |
| 2009 Q1 | 8287.00 CAD | 104.55% |
| 2008 FY | -21.39 Thousand CAD | -40.84% |
| 2008 Q4 | -181.95 Thousand CAD | -858.98% |
| 2008 Q1 | 138.49 Thousand CAD | 105.14% |
| 2008 Q2 | -1905.00 CAD | -101.38% |
| 2008 Q3 | 23.97 Thousand CAD | 1358.48% |
| 2007 FY | -15.19 Thousand CAD | -100.17% |
| 2007 Q4 | -2.69 Million CAD | -448.13% |
| 2007 Q3 | -491.37 Thousand CAD | -113.13% |
| 2007 Q2 | 3.74 Million CAD | 751.83% |
| 2007 Q1 | -574.22 Thousand CAD | -105.87% |
| 2006 FY | 9.11 Million CAD | 249.62% |
| 2006 Q1 | -546.32 Thousand CAD | 84.73% |
| 2006 Q4 | 9.77 Million CAD | 2192.03% |
| 2006 Q2 | -544.26 Thousand CAD | 0.38% |
| 2006 Q3 | 426.49 Thousand CAD | 178.36% |
| 2005 Q4 | -3.57 Million CAD | -429.16% |
| 2005 FY | -6.08 Million CAD | -28.21% |
| 2005 Q1 | -858.75 Thousand CAD | 70.04% |
| 2005 Q3 | -675.97 Thousand CAD | 30.87% |
| 2005 Q2 | -977.82 Thousand CAD | -13.87% |
| 2004 Q3 | -634.46 Thousand CAD | -13.14% |
| 2004 FY | -4.74 Million CAD | -170.85% |
| 2004 Q1 | -665.5 Thousand CAD | -444.92% |
| 2004 Q2 | -560.76 Thousand CAD | 15.74% |
| 2004 Q4 | -2.86 Million CAD | -351.81% |
| 2003 Q4 | 192.94 Thousand CAD | 128.89% |
| 2003 Q3 | -667.85 Thousand CAD | 9.6% |
| 2003 Q2 | -738.81 Thousand CAD | -36.83% |
| 2003 Q1 | -539.93 Thousand CAD | 90.43% |
| 2003 FY | -1.75 Million CAD | 74.9% |
| 2002 FY | -6.98 Million CAD | -283.49% |
| 2002 Q3 | -420.8 Thousand CAD | 12.95% |
| 2002 Q4 | -5.64 Million CAD | -1240.8% |
| 2002 Q1 | -441.53 Thousand CAD | -112.08% |
| 2002 Q2 | -483.41 Thousand CAD | -9.49% |
| 2001 Q1 | -103.06 Thousand CAD | 98.56% |
| 2001 Q3 | 477.12 Thousand CAD | 316.71% |
| 2001 Q2 | -220.16 Thousand CAD | -113.63% |
| 2001 Q4 | 3.65 Million CAD | 665.91% |
| 2001 FY | 3.8 Million CAD | 153.17% |
| 2000 Q2 | 30.21 Thousand CAD | 37.16% |
| 2000 Q1 | 22.02 Thousand CAD | -91.51% |
| 2000 FY | -7.16 Million CAD | -1037.32% |
| 2000 Q3 | -68.35 Thousand CAD | -326.23% |
| 2000 Q4 | -7.14 Million CAD | -10354.89% |
| 1999 FY | -629.72 Thousand CAD | -2092.56% |
| 1999 Q1 | 64.85 Thousand CAD | 0.0% |
| 1999 Q4 | 259.33 Thousand CAD | 26.54% |
| 1999 Q2 | -1.15 Million CAD | -1886.89% |
| 1999 Q3 | 204.94 Thousand CAD | 117.68% |
| 1998 Q1 | 11.41 Thousand CAD | -39.41% |
| 1998 Q2 | 18.98 Thousand CAD | 66.37% |
| 1998 FY | -28.72 Thousand CAD | -84.63% |
| 1997 FY | -15.55 Thousand CAD | 0.0% |
| 1997 Q4 | 18.83 Thousand CAD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Aurora Cannabis Inc. | -69.32 Million CAD | 35.795% |
| Avicanna Inc. | -8.74 Million CAD | -409.104% |
| Avant Brands Inc. | -5.07 Million CAD | -777.929% |
| Cardiol Therapeutics Inc. | -28.12 Million CAD | -58.243% |
| Crescita Therapeutics Inc. | -1.98 Million CAD | -2141.239% |
| Knight Therapeutics Inc. | -16.83 Million CAD | -164.396% |
| MediPharm Labs Corp. | -13.08 Million CAD | -240.22% |
| OrganiGram Holdings Inc. | -229.47 Million CAD | 80.603% |
| Canopy Growth Corporation | -657.26 Million CAD | 93.228% |
| Willow Biosciences Inc. | -13.02 Million CAD | -241.63% |